AHF: as Gilead Sciences, Inc. Prepares to Price the "Quad," 20 California Legislators Say Aids Drug Pricing "Unsustainable"

Published: Aug 20, 2012

SACRAMENTO, Calif.--(BUSINESS WIRE)--AIDS Healthcare Foundation today lauded California Assemblymember Betsy Butler (D, 53rd Assembly District) for a letter she wrote—and which nineteen fellow California state legislators cosigned—to Dr. Ron Chapman, Director of California’s Department of Public Health in which the legislators expressed concern about the rising costs of drugs to treat people with HIV/AIDS served by California’s AIDS Drug Assistance Program (ADAP) and encouraged Chapman’s department to, “…employ all the levers of influence and authority that the government possesses, independently and in partnership with other states, to reduce the price of prescription drugs used to treat HIV/AIDS and its co-morbidities.”

Back to news